Skip to main content

Table 1 Patients characteristics

From: Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study

  n = 335
Male / Female, n (%) 233 (70) / 102 (30)
Age (years) 62 ± 11
BMI (kg/m2) 24.8 ± 3.8
Hypertension, n (%) 224 (67)
Diabetes mellitus, n (%) 92 (28)
 HbA1c (%) 6.1 ± 0.9
Current smoking, n (%) 26 (7.8)
Dyslipidemia, n (%) 269 (80)
eGFR (ml/min/1.73 m2) 69 ± 17
 CKD Stage 3≥, n (%) 89 (27)
Number of risk factors 4.0 ± 1.5
Cardiovascular disease, n (%) 100 (30)
 Coronary artery disease 87 (26)
 Cerebral infarction 12 (3.6)
 Aortic dissection/aortic aneurysm 4 (1.2)
 Peripheral arterial disease 3 (0.9)
Concomitant drug, n (%)
 Anti-platelets 101 (30)
 ACEs/ARBs 191 (57)
 β blockers 77 (23)
 Calcium channel blockers 183(55)
 Lipid-modifying drugs 201(60)
  Statins 179 (53)
  Fibrates 8 (2.4)
  Ezetimibe 15 (4.5)
  1. BMI body mass index, Hb hemoglobin, e-GFR estimated glomerular flow rate, CKD chronic kidney disease, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker